ACADIA Pharmaceuticals Inc. (ACAD)
USD 14.1
(-3.49%)
USD 14.1
(-3.49%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 680.7 Million USD | 34.24% |
| 2022 | 507.06 Million USD | 9.05% |
| 2021 | 465 Million USD | 10.4% |
| 2020 | 421.2 Million USD | 31.84% |
| 2019 | 319.47 Million USD | 55.48% |
| 2018 | 205.47 Million USD | 83.72% |
| 2017 | 111.84 Million USD | 765.31% |
| 2016 | 12.92 Million USD | 116.94% |
| 2015 | -76.3 Million USD | -26.17% |
| 2014 | -60.48 Million USD | -136.47% |
| 2013 | -25.57 Million USD | -84.18% |
| 2012 | -13.88 Million USD | -771.84% |
| 2011 | 2.06 Million USD | -95.09% |
| 2010 | 42.13 Million USD | 558.46% |
| 2009 | 6.39 Million USD | 302.45% |
| 2008 | 1.59 Million USD | -78.95% |
| 2007 | 7.55 Million USD | -7.11% |
| 2006 | 8.13 Million USD | -25.77% |
| 2005 | 10.95 Million USD | 137.96% |
| 2004 | 4.6 Million USD | -37.6% |
| 2003 | 7.37 Million USD | 17.57% |
| 2002 | 6.27 Million USD | 68.97% |
| 2001 | 3.71 Million USD | -13.87% |
| 2000 | 4.31 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 182.88 Million USD | -14.2% |
| 2024 Q2 | 223.73 Million USD | 22.34% |
| 2023 Q1 | 116.79 Million USD | -12.89% |
| 2023 Q2 | 157.77 Million USD | 35.09% |
| 2023 FY | 680.7 Million USD | 34.24% |
| 2023 Q4 | 213.15 Million USD | 8.16% |
| 2023 Q3 | 197.07 Million USD | 24.91% |
| 2022 Q1 | 112.51 Million USD | -12.23% |
| 2022 FY | 507.06 Million USD | 9.05% |
| 2022 Q4 | 134.07 Million USD | 4.28% |
| 2022 Q3 | 128.57 Million USD | -2.52% |
| 2022 Q2 | 131.89 Million USD | 17.22% |
| 2021 Q3 | 124.93 Million USD | 13.56% |
| 2021 Q4 | 128.19 Million USD | 2.62% |
| 2021 FY | 465 Million USD | 10.4% |
| 2021 Q1 | 101.86 Million USD | -11.96% |
| 2021 Q2 | 110.01 Million USD | 8.0% |
| 2020 Q4 | 115.7 Million USD | -0.06% |
| 2020 FY | 421.2 Million USD | 31.84% |
| 2020 Q1 | 85.09 Million USD | -8.49% |
| 2020 Q2 | 104.62 Million USD | 22.96% |
| 2020 Q3 | 115.77 Million USD | 10.65% |
| 2019 Q2 | 78.21 Million USD | 33.97% |
| 2019 Q4 | 92.99 Million USD | 3.44% |
| 2019 Q1 | 58.37 Million USD | 5.8% |
| 2019 Q3 | 89.89 Million USD | 14.94% |
| 2019 FY | 319.47 Million USD | 55.48% |
| 2018 Q2 | 51.98 Million USD | 14.55% |
| 2018 FY | 205.47 Million USD | 83.72% |
| 2018 Q4 | 55.17 Million USD | 4.25% |
| 2018 Q3 | 52.93 Million USD | 1.82% |
| 2018 Q1 | 45.38 Million USD | 13.86% |
| 2017 Q3 | 32.36 Million USD | 18.69% |
| 2017 FY | 111.84 Million USD | 765.31% |
| 2017 Q1 | 12.34 Million USD | 27.96% |
| 2017 Q2 | 27.26 Million USD | 120.84% |
| 2017 Q4 | 39.85 Million USD | 23.15% |
| 2016 Q1 | -22.77 Million USD | 0.78% |
| 2016 FY | 12.92 Million USD | 116.94% |
| 2016 Q3 | 3.94 Million USD | 683.16% |
| 2016 Q4 | 9.65 Million USD | 144.43% |
| 2016 Q2 | -677 Thousand USD | 97.03% |
| 2015 FY | -76.3 Million USD | -26.17% |
| 2015 Q4 | -22.94 Million USD | -22.79% |
| 2015 Q3 | -18.69 Million USD | -1.7% |
| 2015 Q2 | -18.37 Million USD | -12.81% |
| 2015 Q1 | -16.29 Million USD | 10.17% |
| 2014 Q3 | -16.93 Million USD | -22.99% |
| 2014 FY | -60.48 Million USD | -136.47% |
| 2014 Q1 | -11.63 Million USD | -47.54% |
| 2014 Q4 | -18.13 Million USD | -7.07% |
| 2014 Q2 | -13.77 Million USD | -18.33% |
| 2013 FY | -25.57 Million USD | -84.18% |
| 2013 Q1 | -4.01 Million USD | 11.24% |
| 2013 Q2 | -6.66 Million USD | -65.99% |
| 2013 Q3 | -7.01 Million USD | -5.3% |
| 2013 Q4 | -7.88 Million USD | -12.46% |
| 2012 FY | -13.88 Million USD | -771.84% |
| 2012 Q1 | 450 Thousand USD | -23.47% |
| 2012 Q2 | 599 Thousand USD | 33.11% |
| 2012 Q3 | -922 Thousand USD | -253.92% |
| 2012 Q4 | -4.52 Million USD | -390.35% |
| 2011 FY | 2.06 Million USD | -95.09% |
| 2011 Q2 | 460 Thousand USD | 5.75% |
| 2011 Q3 | 584 Thousand USD | 26.96% |
| 2011 Q4 | 588 Thousand USD | 0.68% |
| 2011 Q1 | 435 Thousand USD | -98.77% |
| 2010 Q2 | 2.29 Million USD | 7.69% |
| 2010 Q1 | 2.13 Million USD | 20.58% |
| 2010 Q3 | 2.3 Million USD | 0.17% |
| 2010 FY | 42.13 Million USD | 558.46% |
| 2010 Q4 | 35.4 Million USD | 1438.64% |
| 2009 Q2 | 1.82 Million USD | 386.63% |
| 2009 Q4 | 1.76 Million USD | -27.35% |
| 2009 Q3 | 2.43 Million USD | 33.79% |
| 2009 Q1 | 374 Thousand USD | 15.08% |
| 2009 FY | 6.39 Million USD | 302.45% |
| 2008 Q4 | 325 Thousand USD | 15.25% |
| 2008 FY | 1.59 Million USD | -78.95% |
| 2008 Q3 | 282 Thousand USD | 59.32% |
| 2008 Q1 | 806 Thousand USD | -49.08% |
| 2008 Q2 | 177 Thousand USD | -78.04% |
| 2007 Q2 | 2.05 Million USD | 4.85% |
| 2007 Q1 | 1.96 Million USD | 10.55% |
| 2007 FY | 7.55 Million USD | -7.11% |
| 2007 Q4 | 1.58 Million USD | -19.11% |
| 2007 Q3 | 1.95 Million USD | -4.77% |
| 2006 Q4 | 1.77 Million USD | -8.75% |
| 2006 FY | 8.13 Million USD | -25.77% |
| 2006 Q1 | 2.53 Million USD | 3.85% |
| 2006 Q3 | 1.94 Million USD | 3.3% |
| 2006 Q2 | 1.88 Million USD | -25.86% |
| 2005 Q2 | 2.51 Million USD | 8.15% |
| 2005 Q1 | 2.32 Million USD | 114.62% |
| 2005 FY | 10.95 Million USD | 137.96% |
| 2005 Q4 | 2.44 Million USD | -33.5% |
| 2005 Q3 | 3.67 Million USD | 46.09% |
| 2004 Q1 | 923.9 Thousand USD | -49.91% |
| 2004 Q4 | 1.08 Million USD | -31.49% |
| 2004 Q3 | 1.58 Million USD | 55.69% |
| 2004 Q2 | 1.01 Million USD | 9.94% |
| 2004 FY | 4.6 Million USD | -37.6% |
| 2003 Q3 | 1.84 Million USD | -19.14% |
| 2003 Q4 | 1.84 Million USD | 0.0% |
| 2003 FY | 7.37 Million USD | 17.57% |
| 2003 Q1 | 1.84 Million USD | 0.0% |
| 2003 Q2 | 2.28 Million USD | 23.34% |
| 2002 FY | 6.27 Million USD | 68.97% |
| 2001 FY | 3.71 Million USD | -13.87% |
| 2000 FY | 4.31 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | -465.023% |
| Jaguar Health, Inc. | 7.72 Million USD | -8712.869% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 102615.964% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 13614220.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 55.154% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -468.425% |
| ContextLogic Inc. | 59 Million USD | -1053.739% |
| MiMedx Group, Inc. | 266.84 Million USD | -155.096% |
| MEI Pharma, Inc. | 49.32 Million USD | -1279.987% |
| AlloVir, Inc. | -398 Thousand USD | 171131.658% |
| Novavax, Inc. | 639.93 Million USD | -6.371% |
| Aptorum Group Limited | -1.11 Million USD | 61166.953% |
| Ardelyx, Inc. | 106.66 Million USD | -538.196% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -182.762% |
| Psyence Biomedical Ltd. | -240.00 USD | 283627600.0% |
| Vaxcyte, Inc. | -75 Million USD | 1007.608% |
| Precigen, Inc. | 106 Thousand USD | -642075.472% |
| Pharming Group N.V. | 220.1 Million USD | -209.266% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -132075.922% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -67363.429% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -520.109% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 475.235% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 131829.322% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 625.561% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 1601.833% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 3195.948% |
| Acelyrin, Inc. | -115 Thousand USD | 592018.261% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 119312.96% |
| Senti Biosciences, Inc. | -2.68 Million USD | 25471.077% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -16703.407% |
| AbCellera Biologics Inc. | 38.02 Million USD | -1690.154% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 14287.286% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -567155.0% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -2236.867% |
| Chimerix, Inc. | 324 Thousand USD | -209994.444% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -137139.113% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 830229.268% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 2284.014% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 138454.878% |
| Elevation Oncology, Inc. | -39 Thousand USD | 1745500.0% |
| Alkermes plc | 1.37 Billion USD | 50.483% |
| Fortress Biotech, Inc. | 57.85 Million USD | -1076.613% |
| Fortress Biotech, Inc. | 57.85 Million USD | -1076.613% |
| Agenus Inc. | 139.61 Million USD | -387.559% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -4006.328% |
| Dyadic International, Inc. | 922.95 Thousand USD | -73652.732% |
| ImmuCell Corporation | 4.39 Million USD | -15383.668% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -3132.069% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 741.431% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 389424.137% |
| Immix Biopharma, Inc. | -5468.00 USD | 12449002.707% |
| Incyte Corporation | 3.44 Billion USD | 80.216% |
| IO Biotech, Inc. | -756 Thousand USD | 90140.476% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 1553.289% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 5195.926% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 1540577.053% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 793.063% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 1237747.273% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -84776.06% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 129266.224% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -2216.351% |
| NextCure, Inc. | -3.68 Million USD | 18577.362% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -3474.573% |
| Onconetix, Inc. | -1.12 Million USD | 60490.981% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 2449.855% |
| Opthea Limited | 21.72 Thousand USD | -3133905.525% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 1187529.788% |
| PureTech Health plc | -1.6 Million USD | 42564.504% |
| Pyxis Oncology, Inc. | -2 Million USD | 34135.3% |
| Seer, Inc. | 7.02 Million USD | -9587.007% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 6772620.147% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -8548.278% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 17367.826% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -160443.868% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -553.903% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -403.224% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 802.121% |
| ChromaDex Corporation | 50.78 Million USD | -1240.5% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 293507.759% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 977.221% |
| CRISPR Therapeutics AG | 240.95 Million USD | -182.502% |
| Precision BioSciences, Inc. | 40.47 Million USD | -1581.918% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 793.445% |
| Innoviva, Inc. | 261.06 Million USD | -160.742% |
| Summit Therapeutics Inc. | -2.05 Million USD | 33305.171% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -15448.333% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -3059.462% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 574579.074% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 475118.318% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -111674.384% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -117.012% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -26345.455% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 1341656.957% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 9690.11% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 143543.931% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 6545350.0% |
| Soligenix, Inc. | 97.31 Thousand USD | -699415.985% |
| Century Therapeutics, Inc. | -10.8 Million USD | 6397.585% |
| Kura Oncology, Inc. | -849 Thousand USD | 80277.385% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 1114.405% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 463165.306% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -587.311% |
| Autolus Therapeutics plc | -4.86 Million USD | 14086.152% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -1544.774% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 405282.143% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -618.628% |
| GRI Bio, Inc. | 10.84 Million USD | -6178.996% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -26699.597% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 7935.916% |
| IGM Biosciences, Inc. | -211.66 Million USD | 421.604% |
| INmune Bio, Inc. | 155 Thousand USD | -439065.161% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -998.994% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 45290.869% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 105073.676% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 2325392.068% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -169229.851% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 34203.507% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 217577.955% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -620.621% |
| Verastem, Inc. | -62 Thousand USD | 1098012.903% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -27855.072% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 260906.897% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -22387.81% |
| Histogen Inc. | 3.76 Million USD | -17960.653% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -118041.411% |
| Surrozen, Inc. | -27.23 Million USD | 2599.838% |
| Organovo Holdings, Inc. | -5.38 Million USD | 12731.397% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 56595.751% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 2754.135% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -3294.704% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 34379190.909% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -11120.879% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 1014096.514% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -339.758% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -466776.543% |
| Apollomics, Inc. | 127 Thousand USD | -535888.976% |
| Amarin Corporation plc | 165.54 Million USD | -311.201% |
| Mesoblast Limited | -9.81 Million USD | 7035.364% |
| Turnstone Biologics Corp. | 16.5 Million USD | -4023.991% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 716.085% |
| Synaptogenix, Inc. | -6347.00 USD | 10724946.384% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 1334817.647% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -321.842% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 61.272% |
| Better Therapeutics, Inc. | -2.72 Million USD | 25043.422% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 706.901% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -101.344% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 5967017.952% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 10973.898% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 61535.56% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -9201.803% |
| Insmed Incorporated | 239.63 Million USD | -184.06% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -18924.762% |
| OmniAb, Inc. | 14.66 Million USD | -4541.072% |
| Alector, Inc. | -95.05 Million USD | 816.133% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -441.873% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 1666.174% |
| Zai Lab Limited | 170.9 Million USD | -298.3% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -731.376% |
| Aura Biosciences, Inc. | -1.29 Million USD | 52664.17% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -523520.0% |
| Immunic, Inc. | -111 Thousand USD | 613348.649% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -4193.592% |
| Veracyte, Inc. | 248.14 Million USD | -174.315% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 109.74% |
| FibroGen, Inc. | 128.9 Million USD | -428.072% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 120692653.191% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 5934.514% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 79.971% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -174888.689% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -91.562% |
| TG Therapeutics, Inc. | 219.1 Million USD | -210.671% |
| Galecto, Inc. | -830 Thousand USD | 82112.771% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 49248.448% |
| Fortrea Holdings Inc. | 424 Million USD | -60.544% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 889.985% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 120153.968% |
| XBiotech Inc. | -1.74 Million USD | 39131.307% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 61535.56% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 1564.797% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 1001.192% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -827.354% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -3951.098% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -74.971% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 1471.092% |
| Vaxxinity, Inc. | -2.23 Million USD | 30570.278% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -108.326% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 6111.264% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -2683.96% |
| NexImmune, Inc. | -1.02 Million USD | 66512.156% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -12605566.667% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 9679.777% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 93.977% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 1018709.245% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 19269.417% |
| Ainos, Inc. | -253.73 Thousand USD | 268376.495% |
| Pluri Inc. | 322 Thousand USD | -211299.379% |
| Prothena Corporation plc | -129.2 Million USD | 626.858% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -1249.966% |
| Celularity Inc. | 6.75 Million USD | -9977.069% |
| Rallybio Corporation | -150 Thousand USD | 453904.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 2187.607% |
| MeiraGTx Holdings plc | 287 Thousand USD | -237079.791% |
| Omeros Corporation | -69.77 Million USD | 1075.517% |
| Humacyte, Inc. | -76.55 Million USD | 989.231% |
| Immunocore Holdings plc | 248.39 Million USD | -174.046% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 4587.481% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -991.19% |
| Blueprint Medicines Corporation | 236.58 Million USD | -187.723% |
| CalciMedica, Inc. | -58 Thousand USD | 1173731.034% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 47835.344% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -2242.819% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 24034.81% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 2305.43% |
| Pulmatrix, Inc. | -8.22 Million USD | 8381.095% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 58280.0% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 170703.008% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 270.691% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -24424.776% |
| Cytokinetics, Incorporated | -322.59 Million USD | 311.011% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -78858.596% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 199720.528% |
| Vor Biopharma Inc. | -3.49 Million USD | 19593.299% |
| Roivant Sciences Ltd. | 109.23 Million USD | -523.157% |
| Evogene Ltd. | 1.39 Million USD | -48556.612% |
| ProKidney Corp. | -3.16 Million USD | 21580.151% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 1650.159% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -9827.169% |
| CorMedix Inc. | -205.56 Thousand USD | 331243.888% |
| BioLineRx Ltd. | 1.1 Million USD | -61335.56% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 965.257% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 2062845.455% |
| Atai Life Sciences N.V. | -5000.00 USD | 13614220.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 558701.334% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 709168.75% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 49106.911% |
| Sagimet Biosciences Inc. | 2 Million USD | -33935.3% |
| MediciNova, Inc. | 979.7 Thousand USD | -69380.711% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 907.298% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 720004.817% |
| GeoVax Labs, Inc. | -20.72 Million USD | 3385.139% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -178.368% |
| Biomea Fusion, Inc. | -4.2 Million USD | 16303.428% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 21.967% |
| Mereo BioPharma Group plc | 7.42 Million USD | -9066.523% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 219682.581% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 5672650.0% |
| Absci Corporation | -41.84 Million USD | 1726.577% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 13614220.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 991.291% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 27759.732% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -218.481% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 72438.576% |
| Allakos Inc. | -6.14 Million USD | 11184.612% |
| Imunon, Inc. | -720 Thousand USD | 94641.843% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 1086.588% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -43.037% |
| BioAtla, Inc. | -103.73 Million USD | 756.222% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 5967017.952% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 382519.101% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 380.335% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 218976.527% |
| XOMA Corporation | 3.86 Million USD | -17530.303% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 1071.258% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -4501.23% |
| aTyr Pharma, Inc. | -2.38 Million USD | 28605.276% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -5363.13% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 2347362.069% |
| Viridian Therapeutics, Inc. | -1 Million USD | 67630.357% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -5236199900.0% |
| Akari Therapeutics, Plc | -4000.00 USD | 17017750.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -6.879% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -349503.509% |
| UroGen Pharma Ltd. | 73.35 Million USD | -827.999% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 2650.034% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -5863000.775% |
| Orgenesis Inc. | -5.72 Million USD | 11990.061% |
| Entera Bio Ltd. | -56 Thousand USD | 1215646.429% |
| GH Research PLC | -315 Thousand USD | 216197.143% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 360261.905% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 129758.286% |
| Xencor, Inc. | -85.26 Million USD | 898.388% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 308143.824% |
| Replimune Group, Inc. | -2.65 Million USD | 25738.644% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 68086.569% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -282.755% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -349503.509% |
| Portage Biotech Inc. | -54 Thousand USD | 1260666.667% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 720004.817% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 180658.621% |
| OncoCyte Corporation | 413 Thousand USD | -164719.855% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 15143726.251% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 306624424.324% |
| Purple Biotech Ltd. | -196 Thousand USD | 347398.98% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -7490.388% |
| scPharmaceuticals Inc. | 9.78 Million USD | -6858.761% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 6617.078% |
| HilleVax, Inc. | -2.15 Million USD | 31672.635% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 701858.763% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 4536930.179% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 102002.096% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 2959691.304% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 9068731.631% |
| Savara Inc. | -44.26 Million USD | 1637.902% |
| Curis, Inc. | 9.81 Million USD | -6838.192% |
| Daré Bioscience, Inc. | 2.76 Million USD | -24478.465% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 545589.951% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 39469.925% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 298655.263% |
| BeiGene, Ltd. | 2.07 Billion USD | 67.256% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 24446.579% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 270.32% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -1100.794% |
| Erasca, Inc. | -3.73 Million USD | 18339.711% |
| bluebird bio, Inc. | -4.03 Million USD | 16990.968% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 2412411.291% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 64.256% |
| DBV Technologies S.A. | 15.72 Million USD | -4227.988% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 2412411.291% |
| Moderna, Inc. | 2.15 Billion USD | 68.413% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 74494.098% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -8402.448% |
| Molecular Templates, Inc. | 50.39 Million USD | -1250.741% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 127097.388% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -408.795% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 11040.309% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 1830.183% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 712.542% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 19071.739% |
| MacroGenics, Inc. | 50.52 Million USD | -1247.212% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 11262.775% |
| Prime Medicine, Inc. | -147.9 Million USD | 560.232% |
| Aditxt, Inc. | -111.66 Thousand USD | 609723.858% |
| Adagene Inc. | 18.11 Million USD | -3658.421% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -139388.934% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -385.518% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -331.274% |
| SciSparc Ltd. | 2.19 Million USD | -30897.541% |
| Vericel Corporation | 135.57 Million USD | -402.084% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 2717597.704% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 2197201.543% |
| Generation Bio Co. | -73.91 Million USD | 1020.981% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 155867.963% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -1146.281% |
| Invivyd, Inc. | -2.02 Million USD | 33665.385% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 326.268% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 658181.169% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -606.361% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -592.563% |
| ADMA Biologics, Inc. | 88.21 Million USD | -671.618% |
| Clene Inc. | 533 Thousand USD | -127612.195% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -2723.43% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 71229.154% |
| GeoVax Labs, Inc. | -20.72 Million USD | 3385.139% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -34140.744% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 350408.775% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -1266.742% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 9698.223% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 81524.163% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -716.047% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -930945.519% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -1180.437% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 493.045% |
| Trevena, Inc. | 1.45 Million USD | -46683.918% |
| Surrozen, Inc. | -27.23 Million USD | 2599.838% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 192934.561% |
| Cingulate Inc. | -582.91 Thousand USD | 116875.601% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 2195925.806% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 3555.536% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 8992253.236% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 77365.153% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 68997.368% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 1208267.974% |
| Kronos Bio, Inc. | 1.37 Million USD | -49514.14% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 1368.412% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 233218.493% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 139499.239% |
| ImmunityBio, Inc. | -17.89 Million USD | 3904.952% |
| Korro Bio, Inc. | -3.63 Million USD | 18852.231% |
| Kineta, Inc. | 5.43 Million USD | -12429.1% |
| BioVie Inc. | -229.37 Thousand USD | 296862.971% |
| Codexis, Inc. | 57.33 Million USD | -1087.264% |
| Celularity Inc. | 6.75 Million USD | -9977.069% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -16862.522% |
| Celcuity Inc. | -142.77 Thousand USD | 476878.36% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -1345434.691% |
| Cibus, Inc. | 1.42 Million USD | -47769.62% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 182106.952% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 3070.051% |
| IN8bio, Inc. | -2.5 Million USD | 27317.353% |
| Kodiak Sciences Inc. | -25.94 Million USD | 2723.448% |
| Annexon, Inc. | -3.26 Million USD | 20935.813% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 33402.642% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 1730.941% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -106260.313% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 12.563% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -293.574% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 35926.632% |
| Arcellx, Inc. | 108.27 Million USD | -528.659% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 2202.957% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -759.434% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 3318.164% |
| Moolec Science SA | -143.3 Thousand USD | 475105.059% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 1708.55% |
| Geron Corporation | -123.5 Million USD | 651.166% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -20609.036% |
| Royalty Pharma plc | 1.79 Billion USD | 62.054% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 1071.188% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 18845781.063% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -294079.981% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 710.97% |
| Humacyte, Inc. | -76.55 Million USD | 989.231% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 71815.618% |
| 89bio, Inc. | -273 Thousand USD | 249442.857% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 54253.222% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 80371.934% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 553519.512% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -60731.635% |
| Notable Labs, Ltd. | 113 Thousand USD | -602294.69% |
| Liquidia Corporation | 14.6 Million USD | -4562.37% |
| Mustang Bio, Inc. | -2.22 Million USD | 30693.528% |
| Immunovant, Inc. | -231 Thousand USD | 294777.922% |
| Quantum-Si incorporated | 488 Thousand USD | -139388.934% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 1325.195% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 2269120.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -36457.787% |
| Acasti Pharma Inc. | -11 Thousand USD | 6188336.364% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 332773.238% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 105073.676% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 506.363% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -59896.298% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 178762.992% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 34865.373% |
| PepGen Inc. | -1.18 Million USD | 57592.061% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 536088.976% |
| United Therapeutics Corporation | 2.07 Billion USD | 67.116% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 3072.905% |
| Solid Biosciences Inc. | -76.56 Million USD | 989.08% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 824368.917% |
| Immuneering Corporation | -764.13 Thousand USD | 89181.553% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -1027163.673% |
| Belite Bio, Inc | -399 Thousand USD | 170703.008% |
| XOMA Corporation | 3.86 Million USD | -17530.303% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 3497.415% |
| Bionomics Limited | -434.44 Thousand USD | 156782.603% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 63480.447% |
| uniQure N.V. | 2.21 Million USD | -30631.648% |
| Cassava Sciences, Inc. | -89.42 Million USD | 861.22% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 839.343% |
| Forte Biosciences, Inc. | -9000.00 USD | 7563500.0% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 81621.677% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 155867.963% |
| Altimmune, Inc. | -65.37 Million USD | 1141.265% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -88.025% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 63480.447% |
| Compugen Ltd. | 31.45 Million USD | -2064.063% |
| Peak Bio, Inc. | 367.76 Thousand USD | -184990.641% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -2676.579% |
| Benitec Biopharma Inc. | 108 Thousand USD | -630183.333% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 872800.0% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 56684.04% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 37460.373% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 572121.849% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 56684.04% |
| Instil Bio, Inc. | -4.75 Million USD | 14412.574% |
| argenx SE | 1.1 Billion USD | 38.591% |
| Immunome, Inc. | -8.9 Million USD | 7742.371% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 36116.19% |
| Verona Pharma plc | -679.62 Thousand USD | 100259.206% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 389074.857% |
| Shattuck Labs, Inc. | -2.38 Million USD | 28641.132% |
| CervoMed Inc. | -1.29 Million USD | 52719.959% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 28380.266% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 14349.655% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -27447.794% |
| Moolec Science SA | -143.3 Thousand USD | 475105.059% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 166927.439% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 25580.025% |
| AnaptysBio, Inc. | 14.78 Million USD | -4505.277% |
| Design Therapeutics, Inc. | -537 Thousand USD | 126860.894% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 159515.925% |
| NeurAxis, Inc. | 2.15 Million USD | -31462.328% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -31619.758% |
| Lumos Pharma, Inc. | 2 Million USD | -33816.592% |
| Achilles Therapeutics plc | -4.73 Million USD | 14487.393% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 389074.857% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 644250.461% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -2050.135% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -78858.596% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 66059.884% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 1594.481% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -1582937.209% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 82910.949% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 5173424.213% |
| Palisade Bio, Inc. | 246 Thousand USD | -276609.756% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 2062845.455% |
| Beam Therapeutics Inc. | -59.67 Million USD | 1240.746% |
| Neurogene Inc. | -3.26 Million USD | 20967.75% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -388.539% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 18537.324% |
| Sesen Bio, Inc. | 40 Million USD | -1601.765% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 229293.939% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 17003.396% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 7215.89% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -4734.56% |
| Athira Pharma, Inc. | -969 Thousand USD | 70348.297% |
| Vaccinex, Inc. | -16 Million USD | 4353.349% |
| HCW Biologics Inc. | -574.82 Thousand USD | 118519.899% |
| XOMA Corporation | 3.86 Million USD | -17530.303% |
| Nektar Therapeutics | 53.47 Million USD | -1172.871% |
| Arvinas, Inc. | 71.8 Million USD | -848.058% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 915.598% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 1184.358% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 211499.379% |
| Rezolute, Inc. | -36 Thousand USD | 1890950.0% |
| Clene Inc. | 533 Thousand USD | -127612.195% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 53014585.981% |
| BeyondSpring Inc. | 1.75 Million USD | -38775.271% |
| Synlogic, Inc. | -1.92 Million USD | 35479.73% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 1839845.946% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 10850.253% |
| Peak Bio, Inc. | 367.76 Thousand USD | -184990.641% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 3689.654% |
| Krystal Biotech, Inc. | 47.6 Million USD | -1329.904% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -382.459% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -13446.388% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 26390.013% |
| MannKind Corporation | 136.19 Million USD | -399.817% |
| Ikena Oncology, Inc. | -50.49 Million USD | 1448.146% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -525.568% |
| Gossamer Bio, Inc. | -4.38 Million USD | 15623.512% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 270221.429% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 13614220.0% |
| Legend Biotech Corporation | 140.92 Million USD | -383.013% |
| Mural Oncology plc | -2.56 Million USD | 26617.569% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 123640.109% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 680806.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -3179.879% |
| REGENXBIO Inc. | 53.02 Million USD | -1183.649% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 12806.962% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 353943.275% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 39401.732% |
| Vaxart, Inc. | -60.76 Million USD | 1220.264% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 259140.262% |
| Cellectis S.A. | 18 Thousand USD | -3781600.0% |
| Longeveron Inc. | 221 Thousand USD | -307911.765% |
| Repare Therapeutics Inc. | -80.07 Million USD | 950.139% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 37.721% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 52704.791% |
| Revolution Medicines, Inc. | -399.66 Million USD | 270.32% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 1944974.286% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -1389095.918% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 92.091% |
| Denali Therapeutics Inc. | -93.34 Million USD | 829.237% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 2717597.704% |
| Veru Inc. | 7.56 Million USD | -8896.993% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 450898.675% |
| Cingulate Inc. | -582.91 Thousand USD | 116875.601% |
| Passage Bio, Inc. | -3.72 Million USD | 18393.631% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 5651926.636% |
| Exicure, Inc. | -1.42 Million USD | 47935.98% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 177830.026% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -25083.352% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 132875.345% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -899.187% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 455096.09% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 1249.725% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -173993.606% |
| OmniAb, Inc. | 14.66 Million USD | -4541.072% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -3304.722% |
| Lipocine Inc. | -2.85 Million USD | 23977.568% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 37034.672% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 12031.744% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 45290.869% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -803.8% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 1047340.0% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -707.519% |
| Ocugen, Inc. | -33.53 Million USD | 2129.716% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 21627.704% |
| Q32 Bio Inc. | 578 Thousand USD | -117669.204% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 256970.189% |
| Alumis Inc. Common Stock | -1.28 Million USD | 53114.486% |
| Equillium, Inc. | 35.95 Million USD | -1793.059% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 39977.329% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -135856.571% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 16466137.736% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 262920.849% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -160933.044% |
| Dominari Holdings Inc. | 2.03 Million USD | -33284.306% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 371115.583% |
| vTv Therapeutics Inc. | -13.59 Million USD | 5107.032% |
| Bio-Techne Corporation | 773.07 Million USD | 11.948% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -3830.4% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -47.727% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 58329.769% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 2938.641% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -5719.492% |
| Nkarta, Inc. | -5.86 Million USD | 11698.33% |
| BioCardia, Inc. | -7.24 Million USD | 9490.343% |
| Iterum Therapeutics plc | -1.75 Million USD | 38997.486% |